Literature DB >> 33635002

Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics.

Minghai Zhang1, Shanshan Cheng1, Yue Jin1, Nan Zhang1, Yu Wang1,2.   

Abstract

In recent years, cell membrane camouflaging technology has emerged as an important strategy of nanomedicine, and the modification on the membranes is also a promising approach to enhance the properties of the nanoparticles, such as cancer targeting, immune evasion, and phototherapy sensitivity. Indeed, diversified approaches have been exploited to re-engineer the membranes of nanoparticles in several studies. In this review, first we discuss direct modification strategy of cell membrane camouflaged nanoparticles (CM-NP) via noncovalent, covalent, and enzyme-involved methods. Second, we explore how the membranes of CM-NPs can be re-engineered at the cellular level using strategies such as genetic engineering and membranes fusion. Due to the innate biological properties and excellent biocompatibility, the functionalized cell membrane-camouflaged nanoparticles have been widely applied in the fields of drug delivery, imaging, detoxification, detection, and photoactivatable therapy.
© 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

Entities:  

Keywords:  cell membrane camouflaged nanoparticles; membrane engineering; nanoscale therapeutics

Mesh:

Year:  2021        PMID: 33635002      PMCID: PMC7819108          DOI: 10.1002/ctm2.292

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN: 2001-1326


  104 in total

Review 1.  Non-genetic engineering of cells for drug delivery and cell-based therapy.

Authors:  Qun Wang; Hao Cheng; Haisheng Peng; Hao Zhou; Peter Y Li; Robert Langer
Journal:  Adv Drug Deliv Rev       Date:  2014-12-24       Impact factor: 15.470

2.  Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release.

Authors:  Santosh Aryal; Che-Ming J Hu; Ronnie H Fang; Diana Dehaini; Cody Carpenter; Dong-Er Zhang; Liangfang Zhang
Journal:  Nanomedicine (Lond)       Date:  2013-02-14       Impact factor: 5.307

3.  A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery.

Authors:  Zhilan Chai; Xuefeng Hu; Xiaoli Wei; Changyou Zhan; Linwei Lu; Kuan Jiang; Bingxia Su; Huitong Ruan; Danni Ran; Ronnie H Fang; Liangfang Zhang; Weiyue Lu
Journal:  J Control Release       Date:  2017-08-24       Impact factor: 9.776

4.  Distinguishing the optimal binding mechanism of an E3 ubiquitin ligase: Covalent versus noncovalent inhibition.

Authors:  Imane Bjij; Shama Khan; Pritika Ramharak; Driss Cherqaoui; Mahmoud E S Soliman
Journal:  J Cell Biochem       Date:  2019-03-10       Impact factor: 4.429

Review 5.  Tumor microenvironment-activated NIR-II reagents for tumor imaging and therapy.

Authors:  Xue Zhang; Lu An; Qiwei Tian; Jiaomin Lin; Shiping Yang
Journal:  J Mater Chem B       Date:  2020-06-10       Impact factor: 6.331

6.  Surface-Layer Protein-Enhanced Immunotherapy Based on Cell Membrane-Coated Nanoparticles for the Effective Inhibition of Tumor Growth and Metastasis.

Authors:  Min Wu; Xingang Liu; Hongzhen Bai; Lihua Lai; Qi Chen; Guojun Huang; Bin Liu; Guping Tang
Journal:  ACS Appl Mater Interfaces       Date:  2019-03-04       Impact factor: 9.229

Review 7.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

8.  Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy.

Authors:  Hyunjoon Kim; Lin Niu; Peter Larson; Tamara A Kucaba; Katherine A Murphy; Britnie R James; David M Ferguson; Thomas S Griffith; Jayanth Panyam
Journal:  Biomaterials       Date:  2018-02-17       Impact factor: 12.479

9.  Monoclonal TCR-redirected tumor cell killing.

Authors:  Nathaniel Liddy; Giovanna Bossi; Katherine J Adams; Anna Lissina; Tara M Mahon; Namir J Hassan; Jessie Gavarret; Frayne C Bianchi; Nicholas J Pumphrey; Kristin Ladell; Emma Gostick; Andrew K Sewell; Nikolai M Lissin; Naomi E Harwood; Peter E Molloy; Yi Li; Brian J Cameron; Malkit Sami; Emma E Baston; Penio T Todorov; Samantha J Paston; Rebecca E Dennis; Jane V Harper; Steve M Dunn; Rebecca Ashfield; Andy Johnson; Yvonne McGrath; Gabriela Plesa; Carl H June; Michael Kalos; David A Price; Annelise Vuidepot; Daniel D Williams; Deborah H Sutton; Bent K Jakobsen
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

10.  Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment.

Authors:  Weijie Ma; Daoming Zhu; Jinghua Li; Xi Chen; Wei Xie; Xiang Jiang; Long Wu; Ganggang Wang; Yusha Xiao; Zhisu Liu; Fubing Wang; Andrew Li; Dan Shao; Wenfei Dong; Wei Liu; Yufeng Yuan
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more
  7 in total

1.  Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived.

Authors:  Jun Dai; Zhaojun Chen; Shixuan Wang; Fan Xia; Xiaoding Lou
Journal:  Mater Today Bio       Date:  2022-05-05

Review 2.  Nanotechnology-Assisted Cell Tracking.

Authors:  Alessia Peserico; Chiara Di Berardino; Valentina Russo; Giulia Capacchietti; Oriana Di Giacinto; Angelo Canciello; Chiara Camerano Spelta Rapini; Barbara Barboni
Journal:  Nanomaterials (Basel)       Date:  2022-04-20       Impact factor: 5.719

Review 3.  Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery.

Authors:  Na-Hyun Lee; Sumin You; Ali Taghizadeh; Mohsen Taghizadeh; Hye Sung Kim
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

4.  Homotypic targeting of immunomodulatory nanoparticles for enhanced peripheral and central immunity.

Authors:  Yubo Shen; Daoxia Guo; Xiaoyuan Ji; Yanfeng Zhou; Shuo Liu; Jing Huang; Haiyun Song
Journal:  Cell Prolif       Date:  2022-01-27       Impact factor: 6.831

Review 5.  Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.

Authors:  Biao Yu; Xu Xue; Zhifeng Yin; Liehu Cao; Mengmeng Li; Jianping Huang
Journal:  Front Cell Dev Biol       Date:  2022-02-28

Review 6.  Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis.

Authors:  Xinjing Guo; Jia Lou; Fazhan Wang; Daoyang Fan; Zhihai Qin
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

Review 7.  Nanomaterials: A powerful tool for tumor immunotherapy.

Authors:  Ziyin Chen; Ziqi Yue; Ronghua Wang; Kaiqi Yang; Shenglong Li
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.